Anita Jones v. HHS - Tdap, Guillain-Barré syndrome (GBS) (2018)
Case summary [AI summaries can sometimes make mistakes]
On July 18, 2018, Anita Jones filed a petition alleging that she suffered from Guillain-Barré syndrome (GBS) caused by a Tetanus-diphtheria-acellular pertussis (Tdap) vaccine administered on February 9, 2015. She further alleged that she experienced residual effects from the injury for more than six months.
The respondent, the Secretary of Health and Human Services, denied that the Tdap vaccine caused Ms. Jones's GBS.
The parties reached a stipulation to resolve the case, agreeing to settlement terms. Special Master Laura D.
Millman adopted the stipulation and awarded compensation. The award included a lump sum of $165,000.00 for all damages, payable to Anita Jones.
Additionally, $192.38 was awarded to reimburse the State of Ohio Medicaid lien for services rendered on behalf of Ms. Jones.
The decision was issued on July 19, 2018. Petitioner counsel was Simina Vourlis, and respondent counsel was Adriana R.
Teitel. The public decision does not describe the onset of symptoms, specific clinical details, diagnostic tests, treatments, or expert testimony.